Simplicity Wealth’s ADC Therapeutics ADCT Stock Holding History

Simplicity Wealth’s Portfolio ADCT Stock Details ADCT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$13.9K	Buy	+11,391	New	+$13.3K	﹤0.01%	1069

Other funds holding ADCT

Revolve Wealth Partners Hackensack, New Jersey $959M AUM 16.43% 1-Year Est. Return

Wilmington Savings Fund Society Wilmington, Delaware $4.39B AUM 17.99% 1-Year Est. Return

DLK Investment Management Solana Beach, California $275M AUM 10.69% 1-Year Est. Return

State of Alaska Department of Revenue Juneau, Alaska $9.6B AUM 34.67% 1-Year Est. Return

Saxony Capital Management St. Louis, Missouri $238M AUM 19.13% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return

Perigon Wealth Management San Francisco, California $6.5B AUM 20.72% 1-Year Est. Return

Sterling Capital Management Charlotte, North Carolina $4.92B AUM 24.73% 1-Year Est. Return

GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return

Nisa Investment Advisors St. Louis, Missouri $34.7B AUM 25.93% 1-Year Est. Return

Simplicity Wealth's ADCT Position: Q3 2026 in Review

Simplicity Wealth opened a new position in ADC Therapeutics (ADCT) in Q3 2026: 11,391 shares worth $13.9K. The stake represents ﹤0.01% of the portfolio and ranks #1069 among its holdings.

16 funds tracked by Wall St. Rank hold ADCT as of Q3 2026.

Simplicity Wealth held 11,391 shares of ADC Therapeutics worth $13.9K as of Q3 2026.
ADC Therapeutics was a new Simplicity Wealth position in Q3 2026.
ADC Therapeutics made up ﹤0.01% of Simplicity Wealth's portfolio in Q3 2026, its #1069 holding.
16 funds tracked by Wall St. Rank held ADC Therapeutics as of Q3 2026.

Based on Simplicity Wealth's 13F filing for Q3 2026, filed 23 Oct 2026.